Fructosamine and Hb A1c in patients with hemoglobinopathies
Pileire, B.; Moutet, J.P.; Ragoucy, C.M.; Bangou, J.
Clinical Chemistry 34(1): 171-172
1988
ISSN/ISBN: 0009-9147 PMID: 3338149 Document Number: 323241
Document emailed within 1 workday
Related Documents
Frandsen, E.K.; Bacchus, R.A.; Moaz, A.A.; Sabagh, T. 1989: Relative potency of commercial calibrators for fructosamine, and their effect on measurements of fructosamine in serum Clinical Chemistry 35(4): 712Vinci, V.S.; Masotti, G.; Citro, G.; De Marca, S.; Quaglia, C.; Galasso, R. 1990: Importance of the determination of fructosamine in monitoring diabetic patients Medicina 10(1): 25-27
Dominiczak, M.H. 1990: Usefulness of the fructosamine measurement for monitoring diabetic patients Clinical Chemistry 36(2): 412
Patmasiriwat, P.; Choopanya, K.; Kuptamethi, S. 1985: The hemoglobinopathies in iron deficiency patients Journal of the Medical Association of Thailand 68(5): 248-253
Veillon, H.; Bovet, P.; Buchard, P.A.; Darioli, R. 1988: Comparison of fructosamine and Hba1c for the evaluation of metabolic control of diabetic patients Schweizerische Medizinische Wochenschrift 118(52): 1989-1992
Baker, J.; Small, C.; Johnson, R. 1987: Relationship between fructosamine and plasma lipid concentrations in patients with diabetes mellitus Clinical Chemistry 33(4): 629
Yahaya, I.A.; Isah, H.S.; Anaja, P.O. 2006: Serum fructosamine in the assessment of glycaemic status in patients with sickle cell anaemia Nigerian Postgraduate Medical Journal 13(2): 95-98
Znaidi, R.; Hafsia, R.; M'Rad, A.; Belhadj, A.; Kastally, R.; Hafsia, A. 1992: Prevalence of hemoglobinopathies in Nefza: study of 1303 patients La Tunisie Medicale 70(8-9): 400-404
Gordeuk, V.R. 2005: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies Haematologica 90(4): 433-434
Kawanishi, K.; Kajikawa, T.; Tada, S.; Ishida, T. 1995: Fructosamine Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 546-548
Piaserico, G.; Piaserico, P. 1986: Assay for serum fructosamine in diabetes Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 22(3): 303-311
Frandsen, E.K.; Sabagh, T.; Bacchus, R.A. 1988: Serum fructosamine in diabetic pregnancy Clinical Chemistry 34(2): 316-319
Woo, J.; Cockram, C.; Lau, E.; Chan, A.; Swaminathan, R. 1992: Influence of obesity on plasma fructosamine concentration Clinical Chemistry 38(11): 2190-2192
González Buitrago, J.M.; Gómez del Campo, A.; Vega, L.; Navajo, J.A. 1986: Fructosamine in the serum in the diagnosis and follow-up of diabetes Medicina Clinica 86(16): 695-696
Kawanishi, K.; Kajikawa, T. 1989: Significance of fructosamine analysis in clinical tests Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 465-467
Coronel, F.; Macia, M.; Cidoncha, A.; Sanchez, A.; Tornero, F.; Barrientos, A.; Valor, R. 1991: Fructosamine levels in CAPD: its value as glycemic index Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 7: 253-256
Farzana, F. 1975: Hemoglobinopathies JPMA. Journal of the Pakistan Medical Association 25(5): 103-107
Duffy, T.P. 1974: The kidney in hemoglobinopathies Birth Defects Original Article Series 10(4): 60-61
Huntsman, R.G. 1978: Hemoglobinopathies: how big a problem? Canadian Medical Association Journal 119(7): 675-679
De Montalembert, M. 1997: New treatments of hemoglobinopathies Presse Medicale 26(20): 972-976